[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,997,436
  • Shares Outstanding, K 419,228
  • Annual Sales, $ 9,467 M
  • Annual Income, $ 2,673 M
  • EBIT $ 3,435 M
  • EBITDA $ 3,922 M
  • 60-Month Beta 0.75
  • Price/Sales 3.42
  • Price/Cash Flow 10.40
  • Price/Book 10.24

Options Overview Details

View History
  • Implied Volatility 35.62% (-0.74%)
  • Historical Volatility 78.16%
  • IV Percentile 68%
  • IV Rank 54.46%
  • IV High 46.58% on 05/06/26
  • IV Low 22.52% on 08/12/25
  • Expected Move (DTE 27) 5.37 (6.83%)
  • Put/Call Vol Ratio 2.11
  • Today's Volume 6,567
  • Volume Avg (30-Day) 6,696
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 155,555
  • Open Int (30-Day) 141,701
  • Expected Range 73.34 to 84.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.85
  • Number of Estimates 9
  • High Estimate $1.89
  • Low Estimate $1.77
  • Prior Year $1.76
  • Growth Rate Est. (year over year) +5.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
74.87 +5.13%
on 06/02/26
82.98 -5.15%
on 06/10/26
+0.99 (+1.27%)
since 05/18/26
3-Month
72.38 +8.75%
on 05/15/26
123.32 -36.17%
on 04/20/26
-38.64 (-32.93%)
since 03/18/26
52-Week
72.38 +8.75%
on 05/15/26
161.77 -51.34%
on 07/10/25
-76.35 (-49.24%)
since 06/18/25

Most Recent Stories

More News
Zoetis Inc. (ZTS) Class Action Lawsuit: Investors July 27 2026, Deadline - Contact KTMC

Did you buy ZTS securities between January 14, 2025, and May 6, 2026?

ZTS : 78.71 (+1.88%)
ZTS INVESTOR NOTICE: Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

SAN DIEGO , June 18, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zoetis Inc. (NYSE: ZTS) securities between January 14, 2025 and May...

ZTS : 78.71 (+1.88%)
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , June 18, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS ) have opportunity...

ZTS : 78.71 (+1.88%)
SueWallSt Reminds Zoetis Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 27, 2026 - ZTS

Notice to Pension Funds, Asset Managers, and Fiduciaries: Zoetis' Companion Animal Segment Collapse Allegedly Cost Institutional Portfolios Hundreds of Millions

ZTS : 78.71 (+1.88%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines - ZTS

NEW YORK , June 18, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS). Such investors are advised...

ZTS : 78.71 (+1.88%)
Zoetis Inc. (ZTS) Investors: July 27, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP

Did you buy ZTS securities between January 14, 2025, and May 6, 2026? Affected ZTS Investor Summary Who: Zoetis Inc. ( ...

ZTS : 78.71 (+1.88%)
ZTS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zoetis Inc. Securities Lawsuit - Contact Levi & Korsinsky

Zoetis CEO Kristin Peck and CFO Wetteny Joseph Face Personal Liability for Allegedly Certifying Misleading Statements About Companion Animal Product Performance While Safety Concerns and Competitive...

ZTS : 78.71 (+1.88%)
3 S&P 500 Stocks Worth Your Attention

3 S&P 500 Stocks Worth Your Attention

NTRS : 172.11 (-1.62%)
ZTS : 78.71 (+1.88%)
DELL : 409.50 (-2.34%)
ZTS Shareholder Alert: July 27, 2026 Lead Plaintiff Deadline in Zoetis Inc. Securities Class Action - Contact The Gross Law Firm

NEW YORK , June 16, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zoetis Inc. (NYSE: ZTS).

ZTS : 78.71 (+1.88%)
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit

NEW YORK , June 15, 2026 /PRNewswire/ -- 

ZTS : 78.71 (+1.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 81.16
2nd Resistance Point 80.11
1st Resistance Point 79.41
Last Price 78.71
1st Support Level 77.66
2nd Support Level 76.61
3rd Support Level 75.91

See More

52-Week High 161.77
Fibonacci 61.8% 127.62
Fibonacci 50% 117.07
Fibonacci 38.2% 106.53
Last Price 78.71
52-Week Low 72.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.